RecruitingNCT05848310
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Sponsor
Children's Hospital of Fudan University
Enrollment
200 participants
Start Date
Oct 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with biliary atresia and prognosis. The study is currently recruiting participants at 1 location.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05848310
Related Trials
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
NCT07797673
Mapping Disease Pathways for Biliary Atresia
NCT032730491 location
Molecular Characterization for Understanding Biliary Atresia
NCT042725152 locations
The Dirty Nappy Study
NCT076978721 location
Biliary Atresia Study in Infants and Children
NCT0034555316 locations